NCT06422572View on ClinicalTrials.gov

Tissue Kallikrein Protect Against Ischemic Stroke

CompletedOBSERVATIONAL
Enrollment

8,602

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2023

Conditions
Stroke, Ischemic
Interventions
OTHER

No Intervention

No Intervention

Trial Locations (1)

430030

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
collaborator

National Natural Science Foundation of China

OTHER_GOV

lead

Qin Zhang

OTHER

NCT06422572 - Tissue Kallikrein Protect Against Ischemic Stroke | Biotech Hunter | Biotech Hunter